Dr. Jaimie Z. Shing is a postdoctoral fellow at the United States National Cancer Institute, Division of Cancer Epidemiology and Genetics. Dr. Shing received a dual Bachelor of Science in health promotion and behavior/Master of Public Health with a concentration in epidemiology in 2017 from the University of Georgia, Athens, Georgia, where she was inducted into the Delta Omega Honorary Society in Public Health. In 2021, Dr. Shing earned her Doctor of Philosophy in epidemiology from Vanderbilt University, Nashville, Tennessee. Her doctoral research focused on assessing population-level HPV vaccine impact and improving surveillance of cervical premalignant lesions using claims-based prediction models. Currently at the National Cancer Institute, Dr. Shing is working with Dr. Aimée R. Kreimer, senior investigator at the Infections and Immunoepidemiology Branch, to examine HPV vaccine efficacy and impact on HPV-driven cancers.